A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine
- PMID: 1867958
- PMCID: PMC1368573
- DOI: 10.1111/j.1365-2125.1991.tb05586.x
A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine
Abstract
1. The kinetics of codeine and metabolites were studied in eight unrelated healthy Chinese subjects following a single oral dose of 50 mg codeine phosphate. The data were compared with those from eight Caucasian subjects who were matched with the Chinese group according to their metabolic ratio (MR) of debrisoquine. 2. Mean values of Cmax (445 nmol l-1) and AUC (1660 nmol l-1 h) of codeine in the Chinese were significantly higher than those in the Caucasians (292 nmol l-1 and 1010 nmol l-1 h). Thus plasma clearance was significantly lower (P less than 0.02) and the plasma half-life was longer (P less than 0.05) in the Chinese. 3. Partial clearance by glucuronidation was significantly lower (0.79 +/- 0.14 s.d. vs 1.42 +/- 0.48 s.d. 1 h-1 kg-1) in Chinese than in Caucasians. 4. The total urinary recovery of drug-related material in 48 h urine was similar in Chinese (82.2%) and Caucasians (84.4%). The recovery of unchanged codeine was significantly higher in Chinese (5.7%) than in Caucasians (3.3%). 5. The AUC ratios of codeine relative to its 6-glucuronide, morphine and norcodeine were 1:9, 35:1 and 4:1, respectively in Chinese. The corresponding ratios in Caucasians were 1:15, 50:1 and 6:1. 6. There was no significant difference between Chinese and Caucasians in the renal clearances of codeine and its primary metabolites. 7. Large interethnic differences in the kinetics of codeine have been shown. The Chinese are less able to metabolise codeine mainly because of a lower efficiency in glucuronidation.
Similar articles
-
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.Br J Clin Pharmacol. 1991 Jun;31(6):635-42. doi: 10.1111/j.1365-2125.1991.tb05585.x. Br J Clin Pharmacol. 1991. PMID: 1867957 Free PMC article.
-
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.Br J Clin Pharmacol. 1989 Dec;28(6):639-45. doi: 10.1111/j.1365-2125.1989.tb03556.x. Br J Clin Pharmacol. 1989. PMID: 2611086 Free PMC article.
-
Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.Br J Clin Pharmacol. 1989 Dec;28(6):629-37. doi: 10.1111/j.1365-2125.1989.tb03555.x. Br J Clin Pharmacol. 1989. PMID: 2611085 Free PMC article.
-
Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.J Pharmacol Exp Ther. 1999 Jul;290(1):413-22. J Pharmacol Exp Ther. 1999. PMID: 10381807 Clinical Trial.
-
The pharmacogenetics of codeine hypoalgesia.Pharmacogenetics. 1995 Dec;5(6):335-46. doi: 10.1097/00008571-199512000-00001. Pharmacogenetics. 1995. PMID: 8845855 Review.
Cited by
-
Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?Clin Pharmacokinet. 1996 Nov;31(5):372-85. doi: 10.2165/00003088-199631050-00004. Clin Pharmacokinet. 1996. PMID: 9118585 Review.
-
Model-based meta-analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism.CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1132-1142. doi: 10.1002/psp4.12980. Epub 2023 Jun 12. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37309079 Free PMC article.
-
Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.Clin Pharmacokinet. 2013 Dec;52(12):1085-100. doi: 10.1007/s40262-013-0089-y. Clin Pharmacokinet. 2013. PMID: 23818090
-
Drug dosing error with drops: severe clinical course of codeine intoxication in twins.Eur J Pediatr. 2009 Jul;168(7):819-24. doi: 10.1007/s00431-008-0842-7. Epub 2008 Oct 21. Eur J Pediatr. 2009. PMID: 18936971
-
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.Clin Pharmacokinet. 2004;43(14):983-1013. doi: 10.2165/00003088-200443140-00003. Clin Pharmacokinet. 2004. PMID: 15530129 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources